Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis

Samankaltaisia teoksia

• Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand
  Tekijä: Sinha, Sushmita, et al.
  Julkaistu: (2009)
• GILT REQUIRED FOR RTL550-CYS-MOG TO TREAT EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
  Tekijä: Burrows, Gregory G., et al.
  Julkaistu: (2012)
• A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS
  Tekijä: Sinha, Sushmita, et al.
  Julkaistu: (2007)
• Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke
  Tekijä: Subramanian, Sandhya, et al.
  Julkaistu: (2009)
• RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
  Tekijä: Sushmita Sinha, et al.
  Julkaistu: (2011-01-01)